CHD
48
-3
FLS
76
-2
DGX
48
-3
STI
31
19
GILD
56
-4
BMY
61
-3
MLM
57
-3
NWS
79
-4
VNO
60
8
JBHT
63
-5
DLTR
40
4
CHRW
67
3
COF
63
-4
PG
50
2
MAT
38
-3
PSA
58
5
SCHW
65
-2
URBN
66
2
MPC
47
3
SYF
93
-2
CHD
48
-3
FLS
76
-2
DGX
48
-3
STI
31
19
GILD
56
-4
BMY
61
-3
MLM
57
-3
NWS
79
-4
VNO
60
8
JBHT
63
-5
DLTR
40
4
CHRW
67
3
COF
63
-4
PG
50
2
MAT
38
-3
PSA
58
5
SCHW
65
-2
URBN
66
2
MPC
47
3
SYF
93
-2
Financhill
Back

Marker Therapeutics Vs. Protalix BioTherapeutics Industry Stock Comparison

Sell
33

MRKR
Marker Therapeutics

Last Price:
3.50
Seasonality Move:
8.13%
Buy
64

PLX
Protalix BioTherapeutics

Last Price:
1.41
Seasonality Move:
72.04%
Sell
33
Marker Therapeutics (MRKR) is a Sell

Is Marker Therapeutics a Buy, Sell or Hold?

  • The current Marker Therapeutics [MRKR] share price is $3.64. The Score for MRKR is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • MRKR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
64
Protalix BioTherapeutics (PLX) is a Buy

Is Protalix BioTherapeutics a Buy, Sell or Hold?

  • The current Protalix BioTherapeutics [PLX] share price is $1.24. The Score for PLX is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
  • PLX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

MRKR Stock Price Chart

What is Marker Therapeutics's stock price today?

  • The Marker Therapeutics share price today is $3.64
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MRKR is experiencing selling pressure, which indicates risk of future bearish movement.

PLX Stock Price Chart

What is Protalix BioTherapeutics's stock price today?

  • The Protalix BioTherapeutics share price today is $1.24
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PLX is experiencing selling pressure, which indicates risk of future bearish movement.

MRKR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.14 Buy
Relative Strength Index (14 RSI): 48.96 Sell
Chaikin Money Flow: -16950 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.2 - 4.28) Sell
Bollinger Bands (100): (2.94 - 4.8) Sell

PLX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.05 Buy
Relative Strength Index (14 RSI): 57.9 Buy
Chaikin Money Flow: -197064 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.05 - 1.23) Buy
Bollinger Bands (100): (0.99 - 1.17) Buy

MRKR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.86 Sell
20-day SMA: 3.96 Sell
50-day SMA: 3.27 Buy
200-day SMA: 4.04 Sell
8-day EMA: 3.85 Sell
20-day EMA: 3.78 Sell
50-day EMA: 3.61 Buy
200-day EMA: 3.87 Sell

PLX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.24 Buy
20-day SMA: 1.16 Buy
50-day SMA: 1.1 Buy
200-day SMA: 1.18 Buy
8-day EMA: 1.23 Buy
20-day EMA: 1.18 Buy
50-day EMA: 1.12 Buy
200-day EMA: 1.21 Buy

Marker Therapeutics Earnings Growth & MRKR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.71 per share, and a decrease next year of $0.03 per share.

Protalix BioTherapeutics Earnings Growth & PLX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Marker Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Protalix BioTherapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):